Telik, Inc. (TELK) Announces First Quarter 2013 Financial Results
5/13/2013 6:24:52 AM
More...
|
Telik, Inc. (TELK) Announces Fourth Quarter and 2012 Year End Financial Results and 2013 Financial Guidance
3/14/2013 9:52:17 AM
More...
|
Telik, Inc. (TELK) Announces Preliminary Agreement on Design of Phase 3 Registration Trial of Telintra® in Low to Intermediate-1 Risk Myelodysplastic Syndrome
1/23/2013 8:53:40 AM
More...
|
Telik, Inc. (TELK) Announces Orphan Designation of Telintra® for Treatment of Myelodysplastic Syndrome
1/14/2013 9:06:51 AM
More...
|
Telik, Inc. (TELK) Announces Telintra® Clinical Publication at the 54th Annual Meeting of the American Society of Hematology
12/13/2012 9:15:58 AM
More...
|
Telik, Inc. (TELK) Announces Third Quarter 2012 Financial Results
11/12/2012 9:27:53 AM
More...
|
Telik, Inc. (TELK) Announces Second Quarter 2012 Financial Results
8/13/2012 9:50:00 AM
More...
|
Telik, Inc. (TELK) Announces the Publication of Two Reports in the Journal of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Telintra in Patients With Myelodysplastic Syndrome
5/15/2012 10:45:39 AM
More...
|
Telik, Inc. (TELK) Announces First Quarter 2012 Financial Results
5/10/2012 10:41:24 AM
More...
|
Telik, Inc. (TELK) Regains Compliance With Minimum Bid Price Requirement
4/18/2012 9:56:19 AM
More...
|
|